OM
Insider buying
Opaleye Management Inc. bought $136K of GRCE stock
Opaleye Management Inc., 10% owner of Grace Therapeutics, Inc. (GRCE), bought 71,065 shares of GRCE stock worth $136K, per an SEC Form 4 filed Oct 17, 2026.
It was an open-market purchase.
The trade happened on Oct 14, 2026, 3 days before it was made public.
GRCE has moved +4.8% since the trade date, from $1.89 to $1.98 (Oct 20, 2026 close).
- Traded
- Oct 14, 2026
- Disclosed
- Oct 17, 2026
- Filing delay
- 3 days
- Price since
- +4.8%
- Role
- 10% owner
- Source
- SEC Form 4
More GRCE insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.